Uterine monocytes play dual roles in tissue remodeling and inflammation, with their functions fluctuating across reproductive cycle stages, impacting tissue homeostasis.
- Open access
Moving in bioRxiv, medRxiv, Nature Immunology, Blood, Cancer Research, EMBO Journal, Immunity, Journal of bacteriology.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
Uterine monocytes play dual roles in tissue remodeling and inflammation, with their functions fluctuating across reproductive cycle stages, impacting tissue homeostasis.
Elevated reactive oxygen species induce Paneth cell dedifferentiation and reduce antimicrobial function, impairing intestinal innate immunity during inflammation.
TRAM enables receptor-free myddosome formation, sustaining hours-long NF-κB activation and inflammatory gene expression in TLR signaling.
Polyunsaturated fatty acids effectively kill glycolytic Staphylococcus aureus strains, including persisters and small colony variants, by inducing lipid peroxidation.
A causal AI model for early septic shock management achieved comparable survival prediction with fewer variables, guiding fluid and vasopressor therapy in ICU patients.
Microbial adhesion activates Piezo1 to initiate innate immunity, triggering neutrophil recruitment before pattern recognition receptor engagement.
FAD acts as a natural suppressor of cytosolic DNA and RNA sensors, reducing immune activation and inflammation, with levels dropping during viral infections to enhance immunity.
Retinoic acid promotes expansion of CD177+ neutrophils that drive steroid-resistant GI-GVHD, with RA receptor inhibition restoring steroid sensitivity in models.
Thymosin alpha-1 restores chemotherapy-induced antitumor immunity by protecting microRNA ligands of TLR7 in dendritic cells, enhancing tumor control in mice.
Multidimensional immune responses to trauma involve complex, patient-specific interactions across innate, adaptive, neuroendocrine, and metabolic systems, shaping outcomes.
Inhibiting Munc13-4-STX7 interaction with ENDO12 reduces endosomal TLR activation and systemic inflammation, decreasing key inflammatory mediators.
Journals this month
Moving areas, week to 3 Oct 2026